-- This triggers the users table's own RLS policies, which may in turn -- query other tables, causing policy-chain recursion until Postgres -- hits the stack depth limit. -- Fix: Wrap the admin check ...

DROP POLICY IF EXISTS "user_roles_select_all" ON public.user_roles; DROP POLICY IF EXISTS "user_roles_select_policy" ON public.user_roles; DROP POLICY IF EXISTS "user ...

The co-founders of startup Ricursive Intelligence seemed destined to be co-founders. Anna Goldie, CEO, and Azalia Mirhoseini, CTO, are so well-known in the AI community that they were among those AI ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

How must databases adapt to generative AI, and how should databases be integrated with large language models (LLMs)? These are questions that Sailesh Krishnamurthy has grappled with for several years ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

What does it take to keep Chicago running? Chicago Works goes behind the scenes to explore the massive operations and fascinating jobs that power the city. Join host Geoffrey Baer as he meets the ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...